Test Code: ONC011
CEBPA Mutation Testing
Oncogenetics
CEBPA mutation testing is a critical diagnostic and prognostic assay in acute myeloid leukemia (AML), especially in patients with normal cytogenetics. Double (biallelic) CEBPA mutations are associated with a favorable prognosis, while single mutations carry less predictive value. Testing is typically performed using sequencing-based methods (Sanger or NGS) on bone marrow or peripheral blood samples.
Sample Type
Blood in EDTA; Bone marrow (Na Heparin Tube)
Turnaround Time
10 Days days
Courier Requirements
Ship overnight at room temperature to receive next day. Maintain specimen at room temperature.
Pricing
Login to view pricing
Genes Analyzed
11 genes
Chr6q24
Chr8q24
Chr7
Chr11p15.5
Chr14q32
Chr15q11q13
Chr15q11.2
Chr16p13.3
Chr19q13.43
Chr20q13
Chr20
Methodology
Capture-based target enrichment and Next Generation Sequencing.
Need Help with This Test?
Our team of board-certified genomic scientists is available to answer your questions about test selection, sample requirements, and result interpretation.